Position statement on the diagnosis and management of non-alcoholic fatty liver disease. [electronic resource]
Producer: 20191213Description: 531-540 p. digitalISSN:- 1658-3175
- Bariatric Surgery
- Biomarkers -- blood
- Biopsy
- Chalcones -- therapeutic use
- Chenodeoxycholic Acid -- analogs & derivatives
- Diagnostic Imaging
- Healthy Lifestyle
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Insulin -- metabolism
- Liver -- pathology
- Liver Transplantation
- Mass Screening
- Non-alcoholic Fatty Liver Disease -- diagnosis
- Pioglitazone -- therapeutic use
- Prevalence
- Propionates -- therapeutic use
- Thiazolidinediones -- therapeutic use
- Vitamin E -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.